Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.8288
+0.0549 (7.09%)
At close: Mar 6, 2026, 4:00 PM EST
0.8090
-0.0198 (-2.39%)
After-hours: Mar 6, 2026, 7:38 PM EST

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $522.00K in the twelve months ending November 30, 2025, up 5.05% year-over-year. In the fiscal year ending August 31, 2025, Lexaria Bioscience had annual revenue of $705.92K with 52.05% growth.

Revenue (ttm)
$522.00K
Revenue Growth
+5.05%
P/S Ratio
39.51
Revenue / Employee
$74,571
Employees
7
Market Cap
20.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 2025705.92K241.65K52.05%
Aug 31, 2024464.28K238.07K105.24%
Aug 31, 2023226.21K-29.19K-11.43%
Aug 31, 2022255.40K-467.34K-64.66%
Aug 31, 2021722.74K407.95K129.59%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LEXX News

More News